155 related articles for article (PubMed ID: 32928683)
1. Evaluation and evolution of apparent diffusion coefficient (ADC) in image-guided adaptive brachytherapy (IGABT) for cervical cancer.
Kumar R; Kala P; Narayanan GS; Vishwanathan B; Narayanan S; Mandal S; Rao A; Gowda G
Brachytherapy; 2021; 20(1):112-117. PubMed ID: 32928683
[TBL] [Abstract][Full Text] [Related]
2. Apparent diffusion coefficients in GEC ESTRO target volumes for image guided adaptive brachytherapy of locally advanced cervical cancer.
Haack S; Pedersen EM; Jespersen SN; Kallehauge JF; Lindegaard JC; Tanderup K
Acta Oncol; 2010 Oct; 49(7):978-83. PubMed ID: 20831485
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MRI in image-guided adaptive brachytherapy: Tumor delineation feasibility study and comparison with GEC-ESTRO guidelines.
Schernberg A; Balleyguier C; Dumas I; Gouy S; Escande A; Bentivegna E; Morice P; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2017; 16(5):956-963. PubMed ID: 28673762
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Comparison of Computed Tomography with Transrectal Ultrasonography Assistance and Magnetic Resonance Imaging-Based Target-Volume Definition During Image Guided Adaptive Brachytherapy for Cervical Cancers.
Mahantshetty U; Naga Ch P; Khadanga CR; Gudi S; Chopra S; Gurram L; Jamema S; Ghadi Y; Shrivastava S
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1448-1456. PubMed ID: 30146092
[TBL] [Abstract][Full Text] [Related]
5. A prospective study of DWI, DCE-MRI and FDG PET imaging for target delineation in brachytherapy for cervical cancer.
Han K; Croke J; Foltz W; Metser U; Xie J; Shek T; Driscoll B; Ménard C; Vines D; Coolens C; Simeonov A; Beiki-Ardakani A; Leung E; Levin W; Fyles A; Milosevic MF
Radiother Oncol; 2016 Sep; 120(3):519-525. PubMed ID: 27528120
[TBL] [Abstract][Full Text] [Related]
6. Hybrid TRUS/CT with optical tracking for target delineation in image-guided adaptive brachytherapy for cervical cancer.
Smet S; Nesvacil N; Knoth J; Sturdza A; Najjari-Jamal D; Jelinek F; Kronreif G; Pötter R; Widder J; Kirisits C; Schmid MP
Strahlenther Onkol; 2020 Nov; 196(11):983-992. PubMed ID: 32621011
[TBL] [Abstract][Full Text] [Related]
7. Transrectal ultrasound for image-guided adaptive brachytherapy in cervix cancer - An alternative to MRI for target definition?
Schmid MP; Nesvacil N; Pötter R; Kronreif G; Kirisits C
Radiother Oncol; 2016 Sep; 120(3):467-472. PubMed ID: 26921168
[TBL] [Abstract][Full Text] [Related]
8. A volumetric analysis of GTV
Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
[TBL] [Abstract][Full Text] [Related]
9. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
10. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
[TBL] [Abstract][Full Text] [Related]
11. Magnetic Resonance Imaging-Guided Adaptive Brachytherapy for the Treatment of Cervical Cancer and its Impact on Clinical Outcome.
Singhal S; Veeratterapillay J; Locks S; Morgan D; Patil R; Chamberlain HM
Clin Oncol (R Coll Radiol); 2022 Jul; 34(7):442-451. PubMed ID: 35123850
[TBL] [Abstract][Full Text] [Related]
12. Feasibility of quantitative diffusion-weighted imaging during intra-procedural MRI-guided brachytherapy of locally advanced cervical and vaginal cancers.
Jacobsen MC; Rigaud B; Simiele SJ; Rauch GM; Ning MS; Vedam S; Klopp AH; Stafford RJ; Brock KK; Venkatesan AM
Brachytherapy; 2023; 22(6):736-745. PubMed ID: 37612174
[TBL] [Abstract][Full Text] [Related]
13. Comparison of apparent diffusion coefficient maps to T2-weighted images for target delineation in cervix cancer brachytherapy.
Esthappan J; Ma DJ; Narra VR; Raptis CA; Grigsby PW
J Contemp Brachytherapy; 2011 Dec; 3(4):193-8. PubMed ID: 23346128
[TBL] [Abstract][Full Text] [Related]
14. A prospective comparative dosimetric study between diffusion weighted MRI (DWI) & T2-weighted MRI (T2W) for target delineation and planning in cervical cancer brachytherapy.
Kumar R; Narayanan GS; Vishwanthan B; Narayanan S; Mandal S
Rep Pract Oncol Radiother; 2020; 25(6):1011-1016. PubMed ID: 33299382
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Schmid MP; Lindegaard JC; Mahantshetty U; Tanderup K; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza A; Hoskin P; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Petric P; Ramazanova D; Ristl R; Kannan S; Hawaldar R; Ecker S; Kirchheiner K; Tan LT; Nout R; Nesvacil N; de Leeuw A; Pötter R; Kirisits C;
J Clin Oncol; 2023 Apr; 41(10):1933-1942. PubMed ID: 36599120
[TBL] [Abstract][Full Text] [Related]
16. MRI-guided adaptive radiotherapy in locally advanced cervical cancer from a Nordic perspective.
Lindegaard JC; Fokdal LU; Nielsen SK; Juul-Christensen J; Tanderup K
Acta Oncol; 2013 Oct; 52(7):1510-9. PubMed ID: 23962242
[TBL] [Abstract][Full Text] [Related]
17. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
[TBL] [Abstract][Full Text] [Related]
18. MRI- and PET-Guided Interstitial Brachytherapy for Postsurgical Vaginal Recurrences of Cervical Cancer: Results of Phase II Study.
Chopra S; Engineer R; Shah S; Shukla R; Dora T; Gupta P; Paul SN; Popat P; Swamidas J; Mahantshetty U; Varghese L; Gupta S; Rangrajan V; Shrivastava S
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):310-319. PubMed ID: 31682968
[TBL] [Abstract][Full Text] [Related]
19. Recommendations from gynaecological (GYN) GEC-ESTRO working group - ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer.
Schmid MP; Fokdal L; Westerveld H; Chargari C; Rohl L; Morice P; Nesvacil N; Mazeron R; Haie-Meder C; Pötter R; Nout RA;
Radiother Oncol; 2020 Apr; 145():36-44. PubMed ID: 31874348
[TBL] [Abstract][Full Text] [Related]
20. The MRI-guided two adaptive brachytherapy fractions versus one adaptive brachytherapy fraction in one application for the cervical cancer: a retrospective study.
Song S; Han D; Zhang N; Mao Z; Guo X; Cheng G
Radiat Oncol; 2023 Mar; 18(1):46. PubMed ID: 36879287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
